MannKind Corporation(NASDAQ:MNKD) 
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It...
Website: http://www.mannkindcorp.com
Founded: 1991
Full Time Employees: 232
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.77
H 4.87
L 4.72
C 4.74
V 3,021,270
10EMA 4.74
20EMA 4.74
60EMA 4.74
120EMA 4.74
250EMA 4.74